lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Literatures

Literature evidence

Links to all GeneRIF Items

26524

PubMed (Gene Name)

Literature evidence

15265683 (LATS2)

Lats2 induces apoptosis through downregulating anti-apoptotic proteins, BCL-2 and BCL-x(L), in human lung cancer cells.

19008013 (LATS2)

tumor-specific mutations and down-regulation of the gene expression is observed in non-small cell lung carcinoma patients

24976335 (LATS2)

LATS2 expression level is predictive of survival in patients with resected lung AD. LATS2 may modulate and contribute to tumor growth via different signaling pathways in EGFR mutant and wild-type tumors.

25946971 (LATS2)

Loss of LATS2 expression is associated with lung cancer.

27195672 (LATS2)

Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.

27470365 (LATS2)

overexpression of LATS2 resulted in mobility inhibition in non-small cell lung cancer cell lines A549 and H1299, and reduced protein level of matrix metalloproteinase-2 (MMP-2) and MMP-9.

30551520 (LATS2)

LATS2 is a tumor suppressor of lung cancer via triggering mitochondrial fission and activation of the JNK-Mff signaling pathway.

31646568 (LATS2)

LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.

31820862 (LATS2)

downregulated LATS2 expression may predict aggressive biologic behavior and a worse prognosis in non-small cell lung carcinoma

32534707 (LATS2)

Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.